What is he best known for?
The fields of study he is best known for:
- Cancer
- Surgery
- Internal medicine
His primary scientific interests are in Surgery, Survival rate, Carcinoma, Cancer and Rectum.
He combines subjects such as Colorectal cancer, Melanoma and Lymph node with his study of Surgery.
His studies deal with areas such as Lymphadenectomy, Sarcoma, Rhabdomyosarcoma, Chemoradiotherapy and Abdominoperineal resection as well as Survival rate.
His biological study spans a wide range of topics, including Breast carcinoma, Biopsy, Stage, Mastectomy and Survival analysis.
His study on Cancer is covered under Internal medicine.
The various areas that he examines in his Internal medicine study include Gastroenterology and Oncology.
His most cited work include:
- Cancer of the stomach. A patient care study by the American College of Surgeons. (568 citations)
- Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. (529 citations)
- Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer (405 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Surgery, Internal medicine, Cancer, Oncology and Stage.
His research in Surgery intersects with topics in Colorectal cancer and Carcinoma.
Many of his studies involve connections with topics such as Gastroenterology and Internal medicine.
His work in Cancer addresses issues such as Immunology, which are connected to fields such as Melanoma and Cytotoxic T cell.
In Oncology, Harold J. Wanebo works on issues like Carboplatin, which are connected to Chemoradiotherapy, Head and neck cancer, Induction chemotherapy, Neck dissection and Phases of clinical research.
The study incorporates disciplines such as Adjuvant therapy and Head and neck in addition to Stage.
He most often published in these fields:
- Surgery (46.88%)
- Internal medicine (32.05%)
- Cancer (26.71%)
What were the highlights of his more recent work (between 2002-2019)?
- Internal medicine (32.05%)
- Surgery (46.88%)
- Oncology (21.96%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Surgery, Oncology, Paclitaxel and Carboplatin are his primary areas of study.
His study connects Gastroenterology and Internal medicine.
His studies in Surgery integrate themes in fields like Sentinel lymph node, Lymphadenectomy and Recurrent Rectal Cancer, Colorectal cancer, Abdominoperineal resection.
His Oncology study combines topics from a wide range of disciplines, such as Breast cancer and Tissue microarray.
His Carboplatin research includes themes of Neck dissection, Biopsy, Stage, Chemoradiotherapy and Induction chemotherapy.
His biological study deals with issues like Malignancy, which deal with fields such as Rectum.
Between 2002 and 2019, his most popular works were:
- T1 adenocarcinoma of the rectum: transanal excision or radical surgery? (191 citations)
- Cetuximab With Concurrent Chemoradiation for Esophagogastric Cancer: Assessment of Toxicity (105 citations)
- Thin Melanomas: Predictive Lethal Characteristics from a 30-Year Clinical Experience (103 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Harold J. Wanebo mainly focuses on Internal medicine, Surgery, Oncology, Paclitaxel and Cancer.
He has researched Internal medicine in several fields, including Gastroenterology and Malignant transformation.
Harold J. Wanebo has included themes like Colorectal cancer and Abdominoperineal resection in his Surgery study.
His Oncology research includes elements of Carboplatin, Cetuximab, Breast cancer and Adenocarcinoma.
His Paclitaxel research is multidisciplinary, relying on both Cancer research, Cisplatin, Toxicity, Radiation therapy and MAPK/ERK pathway.
His work carried out in the field of Cancer brings together such families of science as Malignancy and Melanoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
